Development and validation of a high-performance liquid chromatography-mass spectroscopy assay for determination of artesunate and dihydroartemisinin in human plasma.
about
Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.Pharmacokinetic interaction between pyronaridine-artesunate and metoprololDevelopment and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC.Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers.Embryotoxicity and toxicokinetics of the antimalarial artesunate in ratsEffects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin-glucuronide in sheep plasma.A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.Quantification of artemisinin in human plasma using liquid chromatography coupled to tandem mass spectrometry.A rapid method for the quantification of artemisinin in Artemisia annua L. plants cultivated for the first time in Burundi.LC-UV/MS quality analytics of paediatric artemether formulations.Simultaneous Determination of Artesunate and Dihydroartemisinin Concentrations in Human Plasma by High Performance Liquid Chromatography-Mass Spectrometry with Electro-Spray Ionization
P2860
Q33590189-E603C31B-BCCB-4217-B3AB-5019E1FB6858Q34299041-B44EEB3A-72B9-4E25-BFBC-68D64FA4A163Q34553632-35B7D77D-5CB0-494A-8D53-D4C68370BC06Q34669043-07D6E30F-1B7C-493E-9EC0-E434FBC5D591Q34993096-DE62762B-A439-4E14-985F-63C568508D7AQ35771822-865E9902-589D-444C-8501-E4FD64624C5BQ37326475-F25BD8D1-08FC-41A3-A13C-D1CAFBD3C007Q37335755-E6207192-B77E-4C51-8CE7-72C943D8F282Q38980419-070D79B4-583A-4FD7-8835-D84CE9034486Q39044905-BDF0BF5A-0C66-42C8-8B6F-3460D008E232Q39181738-6FEA0E62-1B65-4D04-A76D-30CFED495647Q46716503-2B7A86A4-0B3B-4872-B2A2-3BEA1B4FCB19Q49091558-1D27A73F-D9FE-498D-8C90-80FE58812645Q58145235-E0EF3C42-4B5E-45B7-953C-2893B145FCC2
P2860
Development and validation of a high-performance liquid chromatography-mass spectroscopy assay for determination of artesunate and dihydroartemisinin in human plasma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Development and validation of ...... roartemisinin in human plasma.
@ast
Development and validation of ...... roartemisinin in human plasma.
@en
type
label
Development and validation of ...... roartemisinin in human plasma.
@ast
Development and validation of ...... roartemisinin in human plasma.
@en
prefLabel
Development and validation of ...... roartemisinin in human plasma.
@ast
Development and validation of ...... roartemisinin in human plasma.
@en
P2093
P1476
Development and validation of ...... roartemisinin in human plasma.
@en
P2093
Daryl J Murry
Himanshu Naik
L E Kirsch
P304
P356
10.1016/J.JCHROMB.2004.11.042
P577
2005-02-01T00:00:00Z